跳至主要内容
临床试验/ISRCTN64733264
ISRCTN64733264已完成不适用

A phase III study of neoadjuvant bicalutamide in patients with intermediate risk prostate cancer undergoing radiation therapy

Princess Margaret Hospital (Canada) - Department of Radiation Oncology0 个研究点目标入组 360 人开始时间: 2005年1月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. T1/T2a prostate cancer with:
  • 1.1. Gleason 7, prostate specific antigen (PSA) less than 20 ng/ml
  • 1.2. Gleason less than 7, PSA 10 - 20 ng/ml
  • 2. T2b prostate cancer with:
  • 2.1. PSA less than 20 ng/ml
  • 2.2. Gleason less than or equal to 7

排除标准

  • Not provided at time of registration

研究者

发起方
Princess Margaret Hospital (Canada) - Department of Radiation Oncology

相似试验

进行中(未招募)
1 期
A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma
EUCTR2019-003543-30-ITEORTC AISBL/IVZW250
进行中(未招募)
1 期
A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcomaPrimary high risk leiomyosarcoma or Liposarcoma ofretroperitoneal space or infra-peritoneal spaces of pelvisMedDRA version: 20.0Level: PTClassification code 10073135Term: Dedifferentiated liposarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10024189Term: LeiomyosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-003543-30-FREuropean Organisation for Research and Treatment of Cancer250
进行中(未招募)
1 期
A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma
EUCTR2019-003543-30-CZEuropean Organisation for Research and Treatment of Cancer250
进行中(未招募)
1 期
A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcomaPrimary high risk leiomyosarcoma or Liposarcoma ofretroperitoneal space or infra-peritoneal spaces of pelvisMedDRA version: 20.0Level: PTClassification code 10073135Term: Dedifferentiated liposarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10024189Term: LeiomyosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-003543-30-SKEuropean Organisation for Research and Treatment of Cancer250
进行中(未招募)
1 期
A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma
EUCTR2019-003543-30-PLEuropean Organisation for Research and Treatment of Cancer250